Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Experimental Designs01:16

Experimental Designs

An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitigating Glycemic Disparities: Understanding Contributions of Sociodemographic Variables in the Teamwork, Targets, Technology, and Tight Glycemia (4T) Study.

The Journal of pediatrics·2026
Same author

Building the evidence to address disparities in type 1 diabetes (BEAD-T1D): methods and design of a study examining barriers and promoters to diabetes device use in families with public insurance.

Frontiers in endocrinology·2026
Same author

Contrast Induced Nephropathy in Trauma: A Real Phenomenon?

The American surgeon·2026
Same author

Cost-Effectiveness of Continuous Glucose Monitoring With Remote Patient Monitoring in Pediatric Patients With Newly Diagnosed Type 1 Diabetes in the U.S.

Diabetes care·2026
Same author

A Quantitative Framework for Evaluating the Performance of Algorithm-Directed Whole-Population Remote Patient Monitoring: Tutorial for Type 1 Diabetes Care.

JMIR diabetes·2026
Same author

Diabetes Technology and Therapy in the Pediatric Age Group.

Diabetes technology & therapeutics·2026
Same journal

Are older adult research participants representative of the general population? Results from 19 clinical studies at one academic research center.

Contemporary clinical trials·2026
Same journal

Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD caregiver oncology needs evaluation tool (CONNECT) trial.

Contemporary clinical trials·2026
Same journal

Rationale and design of a CArdiac rehabilitation program on the prevention of CardioTOXicity in breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: A randomized, active control group, open-label trial.

Contemporary clinical trials·2026
Same journal

Evaluating clinical outcomes of using Undermyfork mobile app with Dexcom G7: Protocol for CGM-Undermyfork randomized controlled trial.

Contemporary clinical trials·2026
Same journal

Outcomes of dyadic recruitment in the promoting re-engagement in meaningful activity (PRIMA) trial.

Contemporary clinical trials·2026
Same journal

Overview of the linking exercise for advancing daily stress (LEADS) management and resilience randomized controlled trial in African American families.

Contemporary clinical trials·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Micro-randomization trial design under operational constraints.

Bryan Bunning1, Victor Ritter2, Franziska K Bishop3

  • 1Quantitative Sciences Unit, Section of Biostatistics, Department of Medicine, Stanford University, Stanford, CA, USA; Computational Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.

Contemporary Clinical Trials
|May 25, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a novel design for AI-driven digital health interventions using micro-randomization and treatment allocation policies to overcome real-world clinical constraints. Longer study durations significantly boost power, offering better efficiency for pediatric type 1 diabetes trials.

Keywords:
CGMDiabetesMicro-randomizationMonitoringRemoteWearables

More Related Videos

A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

Related Experiment Videos

Last Updated: May 27, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

Area of Science:

  • Digital Health Interventions
  • Artificial Intelligence in Healthcare
  • Clinical Trial Design

Background:

  • Micro-randomization is key for AI-driven digital health interventions but faces real-world operational and resource challenges.
  • A novel design integrating micro-randomization with treatment allocation policies is proposed, inspired by a pediatric type 1 diabetes program.
  • This approach aims to mitigate constraints encountered in clinical settings.

Purpose of the Study:

  • To propose and evaluate a novel design for AI-driven digital health interventions that addresses operational and resource constraints.
  • To develop a simulation-based tool to support the design and power calculations for such trials.
  • To provide practical design considerations for implementing micro-randomization in clinical practice.

Main Methods:

  • Extensive simulation studies were conducted to evaluate the proposed design's properties.
  • A simulation-based power calculator, MRThreshold, was developed to aid trial design.
  • The impact of operational constraints, resource allocation, and study length on efficiency and power was assessed.

Main Results:

  • Operational constraints leading to imbalanced treatment assignment negatively impacted study efficiency.
  • Increasing study length demonstrated a greater positive impact on statistical power compared to increasing resources.
  • A study duration extension from 16 to 40 weeks resulted in over a 50% increase in power.
  • A 40-week study with 100 patients achieved 84.0% power to detect a 2% change in time in glucose control.

Conclusions:

  • Thoughtful trial design necessitates careful consideration of study length, sample size, and operational capacity.
  • The proposed novel design and accompanying tool effectively balance micro-randomization with treatment allocation policies under operational constraints.
  • This work offers valuable insights for optimizing AI-driven digital health intervention trials in pediatric type 1 diabetes and similar settings.